Impact of 21‐Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

BACKGROUND. The ROXANE Italian prospective study evaluated the impact of the 21‐gene Recurrence Score (RS) results on adjuvant treatment decision for patients with early breast cancer. MATERIALS AND METHODS. Nine centers participated. Physicians used the RS test whenever unsure about adjuvant treatm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Dieci, Maria Vittoria, Guarneri, Valentina, Zustovich, Fable, Mion, Marta, Morandi, Paolo, Bria, Emilio, Merlini, Laura, Bullian, Pierluigi, Oliani, Cristina, Gori, Stefania, Giarratano, Tommaso, Orvieto, Enrico, Griguolo, Gaia, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2019
Gaiak:
Breast Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853101/
https://ncbi.nlm.nih.gov/pubmed/31152079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0103
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak